id
string | trial_context
string | compound
string | dose_regimen
string | baseline_state_summary
string | early_signal_window
string | biomarker_shift_summary
string | cross_system_coupling_notes
string | observed_short_term_effect
string | adaptation_onset_time
string | acute_response_pattern
string | coupling_shift_signature
string | stabilization_direction
string | early_compensation_flag
int64 | trajectory_seed_class
string | confidence_score
float64 | notes
string | constraints
string | gold_checklist
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EAPD-001
|
phase1 healthy
|
compound-A
|
single low dose
|
stable metabolic baseline
|
0-24h
|
glucose down; insulin up mild
|
liver-muscle coupling intact
|
mild metabolic shift
|
t=6h
|
smooth_adjustment
|
tightened metabolic coupling
|
toward_new_stable
| 0
|
durable_seed
| 0.78
|
clean adaptation
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
EAPD-002
|
phase1 patient
|
compound-B
|
daily x3
|
inflamed baseline
|
0-48h
|
cytokine drop then rebound
|
immune-liver coupling oscillates
|
initial symptom relief
|
t=10h
|
oscillatory
|
immune rebound loop
|
unstable
| 1
|
compensatory_seed
| 0.71
|
early rebound
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
EAPD-003
|
phase1 healthy
|
compound-C
|
single high
|
normal baseline
|
0-12h
|
HR up; cortisol spike
|
cardio-endocrine decouple
|
agitation
|
t=2h
|
stress_response
|
decoupled cardio-endocrine
|
destabilizing
| 1
|
destabilizing_seed
| 0.82
|
rapid stress
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
EAPD-004
|
phase1 patient
|
compound-D
|
daily low
|
fatigue baseline
|
0-72h
|
ATP markers rise steady
|
mito-neuro coupling improves
|
energy gain
|
t=18h
|
gradual_alignment
|
mitochondrial coherence rise
|
toward_new_stable
| 0
|
durable_seed
| 0.75
|
positive adaptation
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
EAPD-005
|
phase1 healthy
|
compound-E
|
single dose
|
normal baseline
|
0-24h
|
dopamine spike then normalize
|
neuro-endocrine stable
|
mild alertness
|
t=4h
|
transient_adjustment
|
short coupling fluctuation
|
returns_baseline
| 0
|
neutral_seed
| 0.69
|
neutral
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
EAPD-006
|
phase1 patient
|
compound-F
|
daily
|
autoimmune baseline
|
0-48h
|
inflammation down then drift
|
immune-metabolic drift
|
partial relief
|
t=12h
|
partial_adjustment
|
metabolic strain rising
|
fragile
| 1
|
oscillatory_seed
| 0.73
|
fragile stabilization
|
Under 220 words
|
onset+pattern+coupling+direction+flag+class+confidence
|
What this dataset tests
Whether a system can detect the earliest systemic adaptation to a drug.
It evaluates how the human system begins to stabilize, compensate, or destabilize.
Required outputs
- adaptation_onset_time
- acute_response_pattern
- coupling_shift_signature
- stabilization_direction
- early_compensation_flag
- trajectory_seed_class
- confidence_score
Use case
Early-phase trial interpretation.
Predict long-term tolerance or durability from short-term data.
Identify drugs that induce coherent stabilization vs compensation.
- Downloads last month
- 23